OSPHOS INJECTION DIN 02440776
Status: Marketed
Holder: DECHRA LTD
Health Canada record
| Active ingredient(s) | CLODRONATE DISODIUM (CLODRONATE DISODIUM TETRAHYDRATE) 60 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intramuscular |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 07-Jul-2015 |
|---|
| Current status date | 07-Jul-2015 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Dechra Veterinary Products Inc. — licence 102149, currently licensed, last inspection rating C (2025-05-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CLODRONATE DISODIUM (CLODRONATE DISODIUM TETRAHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 01984837 | BONEFOS | BAYER INC | Solution | CLODRONATE DISODIUM (CLODRONATE DISODIUM TETRAHYDRATE) 60 MG | Cancelled Post Market |
| 01984845 | BONEFOS | BAYER INC | Capsule | CLODRONATE DISODIUM (CLODRONATE DISODIUM TETRAHYDRATE) 400 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 23337 | 2020-03-16 | Supplement to a New Drug Submission (SNDS) | Labelling update, Addition of drug product manufacturing sites, Change in packaging |
| 22132 | 2019-05-07 | Supplement to a New Drug Submission (SNDS) | MANUFACTURING CHANGES |
| 16873 | 2015-05-06 | New Drug Submission (NDS) | |
Request a quote for OSPHOS INJECTION
How to read a Canadian DIN record